Department of Obstetrics and Gynecology, Liv Hospital Ulus, İstanbul, Turkey
Department of Obstetrics and Gynecology, Faculty of Medicine, İstanbul Health Sciences University, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Turkey
Turk J Med Sci. 2020 Jun 23;50(4):978-984. doi: 10.3906/sag-2005-117.
BACKGROUND/AIM: To investigate the risk of de novo stress urinary incontinence (SUI) occurrence in women who were treated for pelvic organ prolapse (POP) with sacrospinous ligament fixation (SSLF) in addition to vaginal hysterectomy (VAH) and antero-posterior colporrhaphy (CAP) over a 24-month follow-up period.
A prospective randomized study was designed. Women without occult or obvious SUI were randomized into either one of the study groups: Group 1: VAH + CAP, and Group 2: VAH + CAP + SSLF. Postoperatively, the patients were reevaluated for de novo SUI occurrence.
A total of 150 women were analyzed [G1 = VAH + CAP (n: 77) and G2 = VAH + CAP + SSLF (n: 73)]. Mean age, parity, body mass index, menopausal status, and preoperative POP degree, grade 1 and grade 2-3 cystocele and rectocele frequencies were similar between the 2 groups. During follow-up period, de novo SUI developed in 7 patients (9.1%) of Group 1, and in 6 patients (8.2%) of Group 2 (P > 0.05). In Groups 1 and 2, POP recurrence occurred in 5 (6.4%) vs. 1 (1.3%) cases,respectively (P < 0.05).
In patients undergoing surgery for POP, the addition of SSLF did not result in an increased rate of de novo SUI. Careful patient selection, and informing the patients about the risks and benefits of the planned surgical procedure are essential steps in each case of POP.
背景/目的:研究在阴道子宫切除术(VAH)和前-后阴道修补术(CAP)的基础上,附加骶骨固定韧带(SSLF)治疗盆腔器官脱垂(POP)的女性在 24 个月随访期间新发压力性尿失禁(SUI)的风险。
设计了一项前瞻性随机研究。无隐匿性或明显 SUI 的女性被随机分为以下研究组之一:组 1:VAH+CAP;组 2:VAH+CAP+SSLF。术后对新发 SUI 的发生情况进行重新评估。
共有 150 名女性被分析[G1:VAH+CAP(n:77)和 G2:VAH+CAP+SSLF(n:73)]。两组之间的平均年龄、产次、体重指数、绝经状态以及术前 POP 程度、1 级和 2-3 级膀胱膨出和直肠膨出的发生率相似。在随访期间,组 1 中有 7 例(9.1%)患者新发 SUI,组 2 中有 6 例(8.2%)患者新发 SUI(P>0.05)。组 1 和组 2 中,POP 复发分别发生在 5 例(6.4%)和 1 例(1.3%)患者中(P<0.05)。
对于接受 POP 手术的患者,附加 SSLF 并不会增加新发 SUI 的发生率。仔细选择患者,并告知患者计划手术的风险和益处,是每个 POP 病例的关键步骤。